Key Statistics
Market Cap$22.81M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$6.33
52W High$12.23
52W Low$1.50
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees4
Price Performance
1 Week+4.61%
3 Month+12.77%
1 Year-60.17%
FinancialsAnnual · QuiverQuant
Revenue—
Assets$51.60M
Liabilities$24.84M
Net Income$29.49M loss
About
Tempest Therapeutics Inc., a clinical-stage oncology company, is dedicated to the development of small molecules that combine targeted and immune-mediated mechanisms with the potential to treat various tumors. The company is headquartered in South San Francisco, California.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze TPST with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.